Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
26 studies found for:    C16011
Show Display Options
Rank Status Study
1 Recruiting Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Condition: Relapsed or Refractory Systemic Light Chain Amyloidosis
Interventions: Drug: IXAZOMIB;   Drug: Dexamethasone;   Drug: Melphalan;   Drug: Cyclophosphamide;   Drug: Thalidomide;   Drug: Lenalidomide
2 Completed Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Biological: secukinumab (AIN457);   Drug: placebo
3 Recruiting Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents
Condition: Rheumatoid Arthritis
Interventions: Biological: Secukinumab (AIN457);   Biological: Placebo
4 Active, not recruiting An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Sarilumab SAR153191 (REGN88);   Drug: Etanercept;   Drug: Adalimumab
5 Recruiting Safety and Efficacy of Extended Treatment With Secukinumab in Anti-TNF Inadequate Responders in RA.
Condition: Rheumatoid Arthritis
Intervention: Biological: Secukinumab (AIN457)
6 Completed
Has Results
3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs
Condition: Post-menopausal Osteoporosis
Interventions: Drug: Placebo;   Drug: Zoledronic acid
7 Completed
Has Results
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
8 Completed AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: metformin;   Drug: sulphonylurea;   Drug: Avandamet
9 Completed
Has Results
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
10 Completed COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: GW406381
11 Completed A Study in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399;   Drug: Placebo every 4 weeks;   Drug: Placebo every 2 weeks
12 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
13 Completed CARISMA Study: A Study of Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta [Mircera]
14 Active, not recruiting Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
15 Recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate
16 Completed
Has Results
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149;   Drug: NVA237;   Drug: tiotropium;   Drug: Salbutamol/albuterol
17 Active, not recruiting A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Condition: Cardiovascular Disease, Rheumatoid Arthritis
Interventions: Drug: etanercept;   Drug: tocilizumab [RoActemra/Actemra]
18 Terminated
Has Results
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Aliskiren;   Drug: Placebo
19 Completed A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: SD-6010;   Drug: Placebo
20 Recruiting Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Secukinumab

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years